{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:22:42Z","timestamp":1725020562907},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T00:00:00Z","timestamp":1254268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00347-009-2030-1","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T15:04:37Z","timestamp":1254150277000},"page":"347-353","source":"Crossref","is-referenced-by-count":12,"title":["Erythropoietin sch\u00fctzt retinale Ganglienzellen und die Sehfunktion nach Isch\u00e4mie und Sehnervkompression im Rattenmodell"],"prefix":"10.1007","volume":"107","author":[{"given":"T.","family":"Jehle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Meschede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,30]]},"reference":[{"key":"2030_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.cdd.4400219","volume":"4","author":"Chappell","year":"1997","unstructured":"Chappell D, Tilbrook PA, Bittorf T et al (1997) Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases. Cell Death Differ 4:105\u2013113","journal-title":"Cell Death Differ"},{"key":"2030_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awh365","volume":"128","author":"Diem","year":"2005","unstructured":"Diem R, Sattler MB, Merkler D et al (2005) Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128:375\u2013385","journal-title":"Brain"},{"key":"2030_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1076\/ceyr.22.1.74.6974","volume":"22","author":"Dureau","year":"2001","unstructured":"Dureau P, Bonnel S, Menasche M et al (2001) Quantitative analysis of intravitreal injections in the rat. Curr Eye Res 22:74\u201377","journal-title":"Curr Eye Res"},{"key":"2030_CR4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm723","volume":"8","author":"Grimm","year":"2002","unstructured":"Grimm C, Wenzel A, Groszer M et al (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718\u2013724","journal-title":"Nat Med"},{"key":"2030_CR5","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1523\/JNEUROSCI.1288-04.2004","volume":"24","author":"Grimm","year":"2004","unstructured":"Grimm C, Wenzel A, Stanescu D et al (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24:5651\u20135658","journal-title":"J Neurosci"},{"key":"2030_CR6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00417-007-0746-7","volume":"246","author":"Jehle","year":"2008","unstructured":"Jehle T, Dimitriu C, Auer S et al (2008) The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 246:1255\u20131263","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2030_CR7","doi-asserted-by":"crossref","unstructured":"Jehle T, Ehlken D, Wingert K et al (2009) Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats. Doc Ophthalmol","DOI":"10.1007\/s10633-008-9160-7"},{"key":"2030_CR8","unstructured":"Jehle T, Kunze D, Wingert K et al (2007) Modulation of Contrast Depth and Flash Frequencies: Effects on Visual Evoked Potentials Recorded in Awake, Freely Moving Brown Norway Rats. Poster Presentation at ARVO\u2019s 2007 Annual Meeting, May 6 \u2013 May 10, 2007 in Fort Lauderdale, Florida:3756\/B3394"},{"key":"2030_CR9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002100000265","volume":"362","author":"Jehle","year":"2000","unstructured":"Jehle T, Lagreze WA, Blauth E et al (2000) Gabapentin-lactam (8-aza-spiro[5,4]decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced [3H]glutmate release and is a neuroprotective agent in amodel of acute retinal ischemia. Naunyn Schmiedebergs Arch Pharmacol 362:74\u201381","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2030_CR10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1167\/iovs.07-1050","volume":"49","author":"Jehle","year":"2008","unstructured":"Jehle T, Wingert K, Dimitriu C et al (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography and histology. Invest Ophthalmol Vis Sci 49:1056\u20131064","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2030_CR11","doi-asserted-by":"crossref","unstructured":"Junk AK, Mammis A, Savitz SI et al (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 9910659\u201310664","DOI":"10.1073\/pnas.152321399"},{"key":"2030_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/exnr.1999.7094","volume":"158","author":"Kermer","year":"1999","unstructured":"Kermer P, Klocker N, Bahr M (1999) Long-term effect of inhibition of ced 3-like caspases on the survival of axotomized retinal ganglion cells in vivo. Exp Neurol 158:202\u2013205","journal-title":"Exp Neurol"},{"key":"2030_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1096\/fj.04-2493fje","volume":"19","author":"Kilic","year":"2005","unstructured":"Kilic U, Kilic E, Soliz J et al (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1\/-2. FASEB J 19:249\u2013251","journal-title":"FASEB J"},{"key":"2030_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2007.01.017","volume":"205","author":"King","year":"2007","unstructured":"King CE, Rodger J, Bartlett C et al (2007) Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 205:48\u201355","journal-title":"Exp Neurol"},{"key":"2030_CR15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.18-03-01038.1998","volume":"18","author":"Klocker","year":"1998","unstructured":"Klocker N, Cellerino A, Bahr M (1998) Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells In vivo. J Neurosci 18:1038\u20131046","journal-title":"J Neurosci"},{"key":"2030_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/exer.2001.1122","volume":"74","author":"Lafuente","year":"2002","unstructured":"Lafuente MP, Villegas-Perez MP, Mayor S et al (2002) Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study. Exp Eye Res 74:181\u2013189","journal-title":"Exp Eye Res"},{"key":"2030_CR17","doi-asserted-by":"crossref","unstructured":"Lagreze WA, Feltgen N, Bach M et al (2009) Feasibility of intravitreal erythropoietin injections in humans. Br J Ophthal, angenommen","DOI":"10.1136\/bjo.2008.156794"},{"key":"2030_CR18","first-page":"1063","volume":"39","author":"Lagreze","year":"1998","unstructured":"Lagreze WA, Knorle R, Bach M et al (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39:1063\u20131066","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2030_CR19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ymthe.2004.07.027","volume":"10","author":"Rex","year":"2004","unstructured":"Rex TS, Allocca M, Domenici L et al (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855\u2013861","journal-title":"Mol Ther"},{"key":"2030_CR20","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","volume":"11","author":"Sattler","year":"2004","unstructured":"Sattler MB, Merkler D, Maier K et al (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11(Suppl 2):S181\u2013S192","journal-title":"Cell Death Differ"},{"key":"2030_CR21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/02713680802366602","volume":"33","author":"Song","year":"2008","unstructured":"Song BJ, Cai H, Tsai JC et al (2008) Intravitreal recombinant human erythropoietin: a safety study in rabbits. Curr Eye Res 33:750\u2013760","journal-title":"Curr Eye Res"},{"key":"2030_CR22","first-page":"459","volume":"106","author":"Tsai","year":"2008","unstructured":"Tsai JC (2008) Safety of intravitreally administered recombinant erythropoietin (an AOS thesis). Trans Am Ophthalmol Soc 106:459\u2013472","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2030_CR23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/02713680500320729","volume":"30","author":"Tsai","year":"2005","unstructured":"Tsai JC, Wu L, Worgul B et al (2005) Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res 30:1025\u20131031","journal-title":"Curr Eye Res"},{"key":"2030_CR24","first-page":"161","volume":"21","author":"Wang","year":"2005","unstructured":"Wang J, Hu H, Lu Y et al (2005) The effects of recombinant human erythropoietin on electroretinogram after raising intraocular pressure in rabbits. Yan Ke Xue Bao 21:161\u2013164","journal-title":"Yan Ke Xue Bao"},{"key":"2030_CR25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1167\/iovs.03-1039","volume":"45","author":"Weishaupt","year":"2004","unstructured":"Weishaupt JH, Rohde G, Polking E et al (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45:1514\u20131522","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2030_CR26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1167\/iovs.07-0721","volume":"49","author":"Zhang","year":"2008","unstructured":"Zhang J, Wu Y, Jin Y et al (2008) Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49:732\u2013742","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2030_CR27","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1745-7254.2008.00885.x","volume":"29","author":"Zhang","year":"2008","unstructured":"Zhang JF, Wu Yl, Xu JY et al (2008) Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacol Sin 29:1383\u20131390","journal-title":"Acta Pharmacol Sin"},{"key":"2030_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jocn.2008.06.013","volume":"16","author":"Zhang","year":"2009","unstructured":"Zhang W, Sun B, Yu Z et al (2009) High dose erythropoietin promotes functional recovery of rats following facial nerve crush. J Clin Neurosci 16:554\u2013556","journal-title":"J Clin Neurosci"},{"key":"2030_CR29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1167\/iovs.06-0757","volume":"48","author":"Zhong","year":"2007","unstructured":"Zhong L, Bradley J, Schubert W et al (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA\/2J glaucoma mice. Invest Ophthalmol Vis Sci 48:1212\u20131218","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2030_CR30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jop.2008.0021","volume":"24","author":"Zhong","year":"2008","unstructured":"Zhong YS, Liu XH, Cheng Y et al (2008) Erythropoietin with retrobulbar administration protects retinal ganglion cells from acute elevated intraocular pressure in rats. J Ocul Pharmacol Ther 24:453\u2013459","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-2030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-009-2030-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-2030-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:57Z","timestamp":1559051457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-009-2030-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1007\/s00347-009-2030-1","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,30]]}}}